Oral methylthioadenosine administration attenuates fibrosis and chronic liver disease progression in Mdr2-/- mice.

Oral methylthioadenosine administration attenuates fibrosis and chronic liver disease progression in Mdr2-/- mice.

<h4>Background</h4>Inflammation and fibrogenesis are directly related to chronic liver disease progression, including hepatocellular carcinoma (HCC) development. Currently there are few therapeutic options available to inhibit liver fibrosis. We have evaluated the hepatoprotective and an...

Full description

Bibliographic Details
Main Authors:	M Ujue Latasa, Carmen Gil-Puig, Maite G Fernández-Barrena, Carlos M Rodríguez-Ortigosa, Jesús M Banales, Raquel Urtasun, Saioa Goñi, Miriam Méndez, Sara Arcelus, Nerea Juanarena, Juan A Recio, Sophie Lotersztajn, Jesús Prieto, Carmen Berasain, Fernando J Corrales, Jon Lecanda, Matías A Avila
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2010-12-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21209952/?tool=EBI

Similar Items

Methylthioadenosine suppresses Salmonella virulence
by: Bourgeois, J, et al.
Published: (2018)

Methylthioadenosine (MTA) inhibits melanoma cell proliferation and <it>in vivo </it>tumor growth
by: Cortés Javier, et al.
Published: (2010-06-01)

Differential neuroprotective effects of 5'-deoxy-5'-methylthioadenosine.
by: Beatriz Moreno, et al.
Published: (2014-01-01)

Expression and function of methylthioadenosine phosphorylase in chronic liver disease.
by: Barbara Czech, et al.
Published: (2013-01-01)

Methylthioadenosine phosphorylase deficiency in tumors: A compelling therapeutic target
by: Na Fan, et al.
Published: (2023-04-01)

Methylthioadenosine reprograms macrophage activation through adenosine receptor stimulation.
by: Peter A Keyel, et al.
Published: (2014-01-01)

Homozygous MTAP deletion in primary human glioblastoma is not associated with elevation of methylthioadenosine
by: Yasaman Barekatain, et al.
Published: (2021-07-01)

Bifidobacterium alleviate metabolic disorders via converting methionine to 5’-methylthioadenosine
by: Qiang Lyu, et al.
Published: (2024-12-01)

Selective killing of tumors deficient in methylthioadenosine phosphorylase: a novel strategy.
by: Martin Lubin, et al.
Published: (2009-05-01)

The impact of methylthioadenosine phosphorylase (MTAP) deficiency in patients with upper tract urothelial carcinoma
by: Wei-Ming Li, et al.
Published: (2016-06-01)

Correction: Selective Killing of Tumors Deficient in Methylthioadenosine Phosphorylase: A Novel Strategy
Published: (2010-01-01)

Correction: Selective Killing of Tumors Deficient in Methylthioadenosine Phosphorylase: A Novel Strategy.
by: Martin Lubin, et al.
Published: (2010-01-01)

Mechanisms of action of Methylthioadenosine: pathways implicated in neuroprotection in models of Multiple Sclerosis and other neurological diseases
by: Errea O, et al.
Published: (2010-11-01)

Human genetic and metabolite variation reveals that methylthioadenosine is a prognostic biomarker and an inflammatory regulator in sepsis
by: Wang, L, et al.
Published: (2017)

Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target?
by: Alex Claveria-Cabello, et al.
Published: (2020-10-01)

Low methylthioadenosine phosphorylase expression is associated with worse survival in patients with acute myeloid leukaemia
by: Yiyu Xiao, et al.
Published: (2024-09-01)

Genomic landscape of non‐small‐cell lung cancer with methylthioadenosine phosphorylase (MTAP) deficiency
by: Prashanth Ashok Kumar, et al.
Published: (2023-01-01)

Caspases compromise SLU7 and UPF1 stability and NMD activity during hepatocarcinogenesis
by: Carla Rojo, et al.
Published: (2024-08-01)

Epigenetics in hepatocellular carcinoma development and therapy: The tip of the icebergKey points
by: Maite G. Fernández-Barrena, et al.
Published: (2020-12-01)

SCR‐7952, a highly selective MAT2A inhibitor, demonstrates synergistic antitumor activities in combination with the S‐adenosylmethionine‐competitive or the methylthioadenosine‐cooperative protein arginine methyltransferase 5 inhibitors in methylthioadenosine phosphorylase‐deleted tumors
by: Zhiyong Yu, et al.
Published: (2024-10-01)

Methylthioadenosine Phosphorylase and Breast Cancer 1 Protein-Associated Protein 1 as Biomarkers for the Peritoneal Mesothelioma
by: Yue Chen, et al.
Published: (2023-12-01)

Characterization of the Methylthioadenosine Phosphorylase Polymorphism rs7023954 - Incidence and Effects on Enzymatic Function in Malignant Melanoma.
by: Katharina Limm, et al.
Published: (2016-01-01)

The Oncometabolite 5′-Deoxy-5′-Methylthioadenosine Blocks Multiple Signaling Pathways of NK Cell Activation
by: Benedikt Jacobs, et al.
Published: (2020-10-01)

Regulation of amphiregulin gene expression by β-catenin signaling in human hepatocellular carcinoma cells: a novel crosstalk between FGF19 and the EGFR system.
by: Maria U Latasa, et al.
Published: (2012-01-01)

Quantitative proteomics analysis reveals possible anticancer mechanisms of 5'-deoxy-5'-methylthioadenosine in cholangiocarcinoma cells.
by: Kankamol Kerdkumthong, et al.
Published: (2024-01-01)

The Tumor Metabolite 5′-Deoxy-5′Methylthioadenosine (MTA) Inhibits Maturation and T Cell-Stimulating Capacity of Dendritic Cells
by: Christina Brummer, et al.
Published: (2024-12-01)

Loss of 5′-Methylthioadenosine Phosphorylase (MTAP) is Frequent in High-Grade Gliomas; Nevertheless, it is Not Associated with Higher Tumor Aggressiveness
by: Weder Pereira de Menezes, et al.
Published: (2020-02-01)

A study on the interaction of rhodamine B with methylthioadenosine phosphorylase protein sourced from an Antarctic soil metagenomic library.
by: Paulina Bartasun, et al.
Published: (2013-01-01)

Crystal Structure of Schistosoma mansoni Adenosine Phosphorylase/5'-Methylthioadenosine Phosphorylase and Its Importance on Adenosine Salvage Pathway.
by: Juliana Roberta Torini, et al.
Published: (2016-12-01)

Caspase-2 in liver disease and hepatocellular carcinoma
by: Amaya Lopez-Pascual, et al.
Published: (2022-10-01)

FGF21 and APOA1 mRNA-based therapies for the treatment of experimental acute pancreatitis
by: Amaya Lopez-Pascual, et al.
Published: (2025-01-01)

5′-Methylthioadenosine strongly suppresses RANKL-induced osteoclast differentiation and function via inhibition of RANK-NFATc1 signalling pathways
by: Purithat Rattajak, et al.
Published: (2023-11-01)

‘ZS-MDR-TB’ versus ‘ZR-MDR-TB’: improving treatment of MDR-TB by identifying pyrazinamide susceptibility
by: Ying Zhang, et al.
Published: (2012-07-01)

Metabolic Regulation as a Consequence of Anaerobic 5-Methylthioadenosine Recycling in <named-content content-type="genus-species">Rhodospirillum rubrum</named-content>
by: Justin A. North, et al.
Published: (2016-09-01)

A DIVA vaccine strain lacking RpoS and the secondary messenger c-di-GMP for protection against salmonellosis in pigs
by: Carmen Gil, et al.
Published: (2020-01-01)

MDR Tuberculosis Treatment
by: Juan Espinosa-Pereiro, et al.
Published: (2022-01-01)

New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming
by: Leticia Colyn, et al.
Published: (2022-05-01)

Gordailu, Centro de Patrimonio Cultural Mueble de Gipuzkoa. Estudios previos
by: Maite Barrio Olano, et al.
Published: (2009-08-01)

Violent storms within the Sea: dense water formation episodes in the NW Mediterranean
by: J. Salat, et al.
Published: (2010-07-01)

The effect of varying multidrug-resistence (MDR) definitions on rates of MDR gram-negative rods
by: Aline Wolfensberger, et al.
Published: (2019-11-01)